Firalis Molecular Precision 2024 Successes

As 2024 wraps up, we reflect on a year filled with growth, innovation, and impactful results!

This year, we expanded our product portfolio by adding cutting-edge platforms like the Illumina NovaSeq X Plus and Olink® Signature Q100 to our labs.
We also earned ISO 20387:2018 certification, further elevating our commitment to quality, and this was made possible by the dedication and hard work of our quality team.
We’ve managed over 150 projects and analyzed more than 15,000 samples—a true testament to the trust our clients place in us and the valuable partnerships we’ve built. We are proud to be helping streamline drug development and accelerate research.
We also had the opportunity to engage directly with our clients through our first Lunch & Learn with Olink® and our first webinar with SPT Labtech, which allowed us to better understand our clients’ needs and research goals and better align our services with their mission to innovate and improve patient treatment and care.
We proudly selected Vincent Anquetil, PhD, Director of Translational Data Science at Alentis Therapeutics, as the winner of our Spatial Omics Grant Program. We’re excited to support his transformative work in cancer immunotherapy using Vizgen technology.

We look forward to continuing our work in 2025, supporting our clients in delivering breakthrough therapies that will improve patient outcomes globally!

→ 2024 Successes